Inadequacy of the current WHO re-treatment regimen in a central Siberian prison: Treatment failure and MDR-TB

International Journal of Tuberculosis and Lung Disease

Volumn 3, Issue 5, 1999, Pages 451-453

  Kimerling, M E ^a,e   Kluge, H ^b   Vezhnina, N ^c   Iacovazzi, T ^b   Demeulenaere, T ^b   Portaels, F ^d   Matthys, F ^b  

^a University of Alabama at Birmingham   (United States)

^b MÉDECINS SANS FRONTIÈRES   (Belgium)

^c Colony 33 Medical Department ^*  (Russian Federation)

^d INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Multidrug resistance; Prisons; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ARTICLE; CLINICAL PROTOCOL; DIRECTLY OBSERVED TREATMENT SHORT COURSE; HUMAN; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PRISON; RETREATMENT; RISK ASSESSMENT; RUSSIAN FEDERATION; SPUTUM CULTURE; SPUTUM SMEAR; TREATMENT FAILURE; TREATMENT OUTCOME; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

ANTITUBERCULAR AGENTS; HUMANS; MICROBIAL SENSITIVITY TESTS; PRISONERS; SIBERIA; TREATMENT FAILURE; TUBERCULOSIS, MULTIDRUG-RESISTANT; WORLD HEALTH ORGANIZATION;

EID: 0032978406     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. World Health Organization. Anti-tuberculosis drug resistance in the world: the WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance 1994-1997. Geneva: WHO Global Tuberculosis Program, 1997.
2. World Health Organization. Treatment of tuberculosis: guidelines for national programmes. Geneva: WHO Global Tuberculosis Program, 1997.
3. Canetti G, Fox W, Khomenko A, et al. Advances in techniques of testing mycobacterial drug sensitivity tests in tuberculosis control programmes. Bull World Health Organ 1969; 41: 24-43.
4. Inderlied CB, Nash K. Antimycobacterial agents: in vitro susceptibility testing, spectra of activity, mechanisms of action and resistance, and assays for activity in biologic fluids. In: Lorian V. ed. Antibiotics in laboratory medicine. 4th ed. Baltimore; Williams and Wilkins 1996: pp 127-75.
5. World Health Organization. Guidelines for the management of drug-resistant tuberculosis. Geneva: WHO Global Tuberculosis Program, 1997.
6. Iseman M D. Treatment of multidrug-resistant tuberculosis. N Engl J Med 1993; 329: 784-791.
7. Drobniewski F, Tayler E, Ignatenko N, et al. Tuberculosis in Siberia: I. An epidemiological and microbiological assessment. Tubercle Lung Dis 1996; 77: 199-206.
8. Coninx R, Pfyffer G E, Mathieu C, et al. Drug resistant tuberculosis in prisons in Azerbaijan: case study. BMJ 1998; 316: 1423-1425.